Biothera Pharmaceuticals to Present Clinical Data from Phase 2 Triple Negative Breast Cancer Study at ASCO 2019 Annual Meeting

    NEXT STORY
    Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association
    PREV STORY
    Innovation Pharmaceuticals Announces Non-Binding Term Sheet Signed with Global Pharmaceutical Company to Develop and Commercialize Brilacidin for the Treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    NaturalShrimp, Inc. Announces Nominations for Board of Director Positions

    author_avatar
    NASDAQ Market News

    Key Opinion Leader Management – Global Industry Analysis and Opportunity Assessment by 2026 | Future Market Insights

    Valley Cottage, NY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Key opinion leaders (KOLs) are ...

    author_avatar
    NASDAQ Market News

    Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

    author_avatar
    NASDAQ Market News